The identification of somatic NF1 mutations in such a wide spectrum of tumors, including types not associated with NF1, indicates that neurofibromin is likely to play a key role in cancer beyond what is evident in the tumor predisposition syndrome NF1. Here, NF1 is linked to cancer.